Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Por Jacot, William, Cottu, Paul, Berger, Frederique, Dubot, Coraline, Venat-Bouvet, Laurence, Lortholary, Alain, Bourgeois, Hugues, Bollet, Marc, Servent, Veronique, Luporsi, Elisabeth, Espié, Marc, Guiu, Severine, D’Hondt, Veronique, Dieras, Veronique, Sablin, Marie-Paule, Brain, Etienne, Neffati, Souhir, Pierga, Jean-Yves, Bidard, Francois-Clement
Publicado no Breast Cancer Res (2019)

RBTT-02. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL

Por Mehta, Minesh, Gondi, Vinai, Ahluwalia, Manmeet, Brown, Paul
Publicado no Neuro Oncol (2019)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL

Por Mehta, Minesh P, Gondi, Vinai, Brown, Paul, Ahluwalia, Manmeet
Publicado no Neurooncol Adv (2020)

Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial

Por Hamy, Anne-Sophie, Tury, Sandrine, Wang, Xiaofei, Gao, Junheng, Pierga, Jean-Yves, Giacchetti, Sylvie, Brain, Etienne, Pistilli, Barbara, Marty, Michel, Espié, Marc, Benchimol, Gabriel, Laas, Enora, Laé, Marick, Asselain, Bernard, Aouchiche, Brice, Edelman, Martin, Reyal, Fabien
Publicado no J Clin Oncol (2019)

RTID-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1-10) FROM NSCLC IN THE PHASE 3 METIS TRIAL

Por Mehta, Minesh, Gondi, Vinai, Brown, Paul, Ahluwalia, Manmeet
Publicado no Neuro Oncol (2020)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL

Por Mehta, Minesh, Gondi, Vinai, Ahluwalia, Manmeet, Brown, Paul
Publicado no Neurooncol Adv (2019)

Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors

Por Bernstock, Joshua D., Bag, Asim K., Fiveash, John, Kachurak, Kara, Elsayed, Galal, Chagoya, Gustavo, Gessler, Florian, Valdes, Pablo A., Madan-Swain, Avi, Whitley, Richard, Markert, James M., Gillespie, G. Yancey, Johnston, James M., Friedman, Gregory K.
Publicado no Hum Gene Ther (2020)

PDCT-12. A PHASE I TRIAL OF TUMOR TREATING FIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE...

Por Hanson, Derek
Publicado no Neuro Oncol (2018)

RBTT-12. A PHASE I STUDY OF EGFRVIII-DIRECTED CAR T CELLS COMBINED WITH PD-1 INHIBITION IN PATIENTS...

Por Bagley, Stephen, Desai, Arati, Binder, Zev, Nasrallah, MacLean, Hwang, Wei-Ting, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, O’Rourke, Donald
Publicado no Neuro Oncol (2019)

Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps...

Por Ellingson, Benjamin M., Kim, Hyun J., Woodworth, Davis C., Pope, Whitney B., Cloughesy, Jonathan N., Harris, Robert J., Lai, Albert, Nghiemphu, Phioanh L., Cloughesy, Timothy F.
Publicado no Radiology (2014)

Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial

Por Cramer, Christina K., Alphonse-Sullivan, Natalie, Isom, Scott, Metheny-Barlow, Linda J., Cummings, Tiffany L., Page, Brandi R., Brown, Doris R., Blackstock, Arthur W., Peiffer, Ann M., Strowd, Roy E., Rapp, Stephen, Lesser, Glenn J., Shaw, Edward G., Chan, Michael D.
Publicado no J Cancer Res Clin Oncol (2018)

A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report(†)

Por Su, Jack M., Thompson, Patrick, Adesina, Adekunle, Li, Xiao-Nan, Kilburn, Lindsay, Onar-Thomas, Arzu, Kocak, Mehmet, Chyla, Brenda, McKeegan, Evelyn, Warren, Katherine E., Goldman, Stewart, Pollack, Ian F., Fouladi, Maryam, Chen, Alice, Giranda, Vincent, Boyett, James, Kun, Larry, Blaney, Susan M.
Publicado no Neuro Oncol (2014)

ATIM-44. A PHASE I FIRST-IN-HUMAN TRIAL OF TWO ADENOVIRAL VECTORS EXPRESSING HSV1-TK AND FLT3L...

Por Lowenstein, Pedro, A Orringer, Daniel, Sagher, Oren, Heth, Jason, Hervey-Jumper, Shawn, Gerald Mammoser, Aaron, Junck, Larry, Leung, Denise, Umemura, Yoshie, Steven Lawrence, Theodore, Miran Kim, Michelle, Richard Wahl, Daniel, McKeever, Paul, Ines Camelo-Piragua, Sandra, Lieberman, Andrew, Venneti, Sriram, Comba, Andrea, Altshuler, David, M Muraszko, Karin, Castro, Maria
Publicado no Neuro Oncol (2019)

LS1 PRACTICAL APPLICATION AND UNDERLYING BIOLOGY OF TUMOR TREATING FIELDS

Por Bota, Daniela
Publicado no Neurooncol Adv (2019)

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Por Prados, Michael D., Yung, W.K.A., Jaeckle, Kurt A., Robins, H. Ian, Mehta, Minesh P., Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy F., Chang, Susan M., Nicholas, M. Kelly, Schiff, David, Greenberg, Harry S., Junck, Larry, Fink, Karen L., Hess, Kenneth R., Kuhn, John
Publicado em 2004

Phase I Trial of Weekly MK-0752 in Children with Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study

Por Hoffman, Lindsey M., Fouladi, Maryam, Olson, James, Daryani, Vinay M., Stewart, Clinton F., Wetmore, Cynthia, Kocak, Mehmet, Onar-Thomas, Arzu, Wagner, Lars, Gururangan, Sridharan, Packer, Roger J., Blaney, Susan M., Gajjar, Amar, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Publicado no Childs Nerv Syst (2015)

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

Por Wen, Patrick Y., Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Norden, Andrew D., Cloughesy, Timothy F., Robins, H. Ian, Lieberman, Frank S., Gilbert, Mark R., Mehta, Minesh P., Drappatz, Jan, Groves, Morris D., Santagata, Sandro, Ligon, Azra H., Yung, W.K. Alfred, Wright, John J., Dancey, Janet, Aldape, Kenneth D., Prados, Michael D., Ligon, Keith L.
Publicado em 2014

Non-Invasive Measurement of Drug and 2-HG Signals Using (19)F and (1)H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032

Por Wenger, Katharina J., Richter, Christian, Burger, Michael C., Urban, Hans, Kaulfuss, Stefan, Harter, Patrick N., Sreeramulu, Sridhar, Schwalbe, Harald, Steinbach, Joachim P., Hattingen, Elke, Bähr, Oliver, Pilatus, Ulrich
Publicado no Cancers (Basel) (2020)

A Phase 1 Trial of Everolimus and Bevacizumab in Children with Recurrent Solid Tumors

Por Santana, Victor M., Sahr, Natasha, Tatevossian, Ruth G., Jia, Sujuan, Campagne, Olivia, Sykes, April, Stewart, Clinton F., Furman, Wayne L., McGregor, Lisa M.
Publicado no Cancer (2020)

Frontiers in brain repair

Por Jandial, Rahul.
Publicado em 2010